Eikon Therapeutics, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -5,029 | -5,113 | -5,105 | |
EBITDA | -88,365 | -77,845 | -74,550 | -56,385 |
EBIT | -93,394 | -82,958 | -79,655 | -62,682 |
Net Income | -88,409 | -82,958 | -79,655 | -71,139 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -65,209 | -90,063 | -41,790 | -62,136 |
Cash | 143,013 | 161,554 | 104,901 | 104,868 |
Basic Shares | 54,148 | 54,138 | 54,138 | 53,984 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -24,176 | ||
EBITDA | -299,235 | -218,391 | -224,210 |
EBIT | -323,411 | -243,783 | -241,958 |
Net Income | -324,248 | -243,814 | -241,997 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -235,257 | -219,602 | -219,361 |
Cash | 104,901 | 129,179 | 112,784 |
Basic Shares | 54,138 | 53,984 | 53,984 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$1.63 |
2026-03-31 | -$2.46 |
2025-12-31 | -$26.23 |